# Network Analysis of Drug Repurposing Across Therapeutic Areas

This project leverages clinical trial data from [ClinicalTrials.gov](https://clinicaltrials.gov/) to identify potential drug repurposing opportunities across therapeutic areas using **network science techniques**. The analysis focuses exclusively on active pharmaceutical interventions (excluding devices and procedures), and considers trials in Phase Iâ€“IV with valid recruitment statuses.

## ğŸ§  Objective

To identify and characterise repurposing opportunities by analysing the co-occurrence of drug interventions across multiple disease categories, using centrality and community detection in a drugâ€“disease network constructed from real-world clinical trials.

## ğŸ“ Project Structure

â”œâ”€â”€ code/
â”‚ â”œâ”€â”€ data_extraction.py # Downloads and filters trials from ClinicalTrials.gov API
â”‚ â”œâ”€â”€ build_graphs.py # Builds bipartite drugâ€“disease and projected networks
â”‚ â”œâ”€â”€ visualisations/
â”‚ â”‚ â”œâ”€â”€ drug_centrality_plot.py # Visualises drug centrality rankings
â”‚ â”‚ â”œâ”€â”€ disease_projection_plot.py # Shows diseaseâ€“disease co-occurrence via shared drugs
â”‚ â”‚ â””â”€â”€ candidate_insights.py # Highlights top repurposing candidates
â”‚ â””â”€â”€ centrality_metrics.py # Calculates degree, betweenness, eigenvector centrality
â”‚
â”œâ”€â”€ data/ # JSON files with filtered trials per therapeutic area
â”œâ”€â”€ graph/ # GraphML files for bipartite and projected networks
â”œâ”€â”€ output/
â”‚ â”œâ”€â”€ centrality_summary.csv # CSV file with centrality scores
â”‚ â””â”€â”€ top_candidate_trials.csv # Disease-trial mappings for top drugs
â”œâ”€â”€ plots/ # All generated figures
â””â”€â”€ README.md


## ğŸ§ª Methodology Overview

1. **Trial Filtering**  
   - Only **drug-based** interventional trials  
   - Status: `Completed`, `Recruiting`, `Active`  
   - Phases: `I`, `II`, `III`, `IV`

2. **Graph Construction**  
   - **Bipartite Network:** Drugs â†” Diseases  
   - **Projections:**  
     - Drugâ€“Drug: shared disease connections  
     - Diseaseâ€“Disease: shared drugs

3. **Centrality Analysis**  
   - **Degree Centrality** â€“ Exposure across diseases  
   - **Betweenness Centrality** â€“ Bridge between disease clusters  
   - **Eigenvector Centrality** â€“ Influence in core clusters

4. **Visualisation**  
   - Top drug hubs coloured and labelled  
   - Network edge labels denote shared entity counts  
   - Disease networks filtered by shared drug threshold

## ğŸ” Key Findings

- **Dexamethasone**, **Rituximab**, and **Prednisone** rank highly across all centrality metrics, suggesting strong repurposing potential.
- Disease clusters linked by common drugs reveal biological and therapeutic overlaps, e.g., inflammation, oncology, and autoimmunity.

## ğŸ“Š Plots Included

- Bipartite Drugâ€“Disease Network
- Drug Centrality Highlights (Degree, Betweenness, Eigenvector)
- Diseaseâ€“Disease Network (based on shared drugs)
- Centrality Summary Table (CSV)

## ğŸ›  Requirements

- Python 3.8+
- `networkx`, `matplotlib`, `requests`, `pandas`

Install dependencies:

```bash
pip install -r requirements.txt



